The challenge in BioTech
Biotech and life-sciences buyers are scientists who evaluate on data and reproducibility, and who purchase on grant and budget cycles rather than quarters. Generic sales outreach bounces off them instantly.
The challenge is reaching principal investigators, lab leads and procurement with credible, technical messaging, and tracking deals that move on research timelines you don't control.
Data-driven
scientists evaluate on evidence, not pitches
Grant cycles
budgets and timelines follow funding
6–10+
stakeholders: lab, PI, procurement, finance
Typical industry ranges from Gartner, Forrester, 6sense and sector reports. Figures vary by segment and deal size.
Who you're really selling to
A typical B2B purchase now involves six to ten decision-makers (Gartner), so we map and target the whole committee, not just the first person who replies. Here's who usually shapes a deal in BioTech.
How Enablemnt wins in BioTech
We target the specific labs, programmes and use cases your product genuinely fits, then write technical, evidence-led messaging a scientist will actually read. Credibility, not volume, earns the reply here.
We account for how science actually buys, grant timelines, budget windows and procurement, so outreach reaches people when funding and need line up.
Then we build the CRM and multichannel sequences to keep research-driven deals moving across long, funding-dependent cycles.
- 01
Target by science
Find the labs and programmes your product is genuinely built for.
- 02
Write for scientists
Technical, evidence-led messaging that respects a data-driven buyer.
- 03
Follow the funding
Time outreach to grant and budget cycles.
- 04
Track the long cycle
A CRM built for research-driven, funding-dependent deals.
What we build for you
Everything below is delivered inside the 14-day sprint, tuned for BioTech, and handed over fully documented.
- A data-backed ideal customer profile and a scored list of biotech accounts, approved by you before any outreach
- Verified, enriched contacts for the full biotech buying committee, deduped and loaded into your CRM
- A CRM configured to how biotech deals actually progress, with the stages, properties and dashboards you need
- Multichannel sequences written for biotech buyers and tested against their real objections before launch
- Domain warm-up and SPF, DKIM and DMARC setup so your first send lands in the inbox, not spam
- A documented playbook and a recorded handoff, so your team owns and can run the whole system
Signals you'll recognise
If a few of these sound familiar, you're the kind of team a sprint is built for.
- Scientific buyers who ignore non-technical outreach
- Buying tied to grant and budget cycles
- No CRM to track long, research-driven deals
Why speed matters in BioTech
In biotech, credibility compounds: the labs you reach with real evidence now become the references that win the next ten.
The sprint builds the targeting, technical messaging and CRM to reach scientific buyers credibly and track deals through long research cycles.
Frequently asked questions
- Our buyers are scientists. Will outbound land?
- With technical, evidence-led messaging aimed at the right labs, yes. We write for a data-driven buyer and track deals through grant and budget cycles.